NCT04609085View on ClinicalTrials.gov

SARS-COV2 Pandemic Serosurvey in a Rare Disease Population

CompletedOBSERVATIONAL

Enrollment

730

Participants

Timeline

Start Date

April 19, 2021

Primary Completion Date

June 8, 2022

Study Completion Date

June 8, 2022

Conditions

SARS-COV2 Virus

Trial Locations (2)

15261

University of Pittsburgh, Pittsburgh

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH